Sotirios Patsilinakos

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Cell‐Free DNA Levels as a Prognostic Marker in Acute Myocardial Infarction

Dionisios G. Antonatos, Sotirios Patsilinakos, Stavros Spanodimos et al. · Annals of the New York Academy of Sciences · 2006 · 115 citations

Red blood cell distribution width as a prognostic marker in patients with heart failure and diabetes mellitus

Αndrew Xanthopoulos, Takeshi Kitai, E Paraskevopoulou et al. · Cardiovascular Diabetology · 2017 · 89 citations · Full text

Multicenter Randomized Evaluation of High Versus Standard Heparin Dose on Incident Radial Arterial Occlusion After Transradial Coronary Angiography

George Hahalis, Marianna Leopoulou, Grigorios Tsigkas et al. · JACC: Cardiovascular Interventions · 2018 · 80 citations

Percutaneous Coronary Intervention, Multicenter Randomized Evaluation, Transradial Coronary Angiography +11

Conversion efficacy of intravenous ibutilide compared with intravenous amiodarone in patients with recent-onset atrial fibrillation and atrial flutter

Nikolaos Kafkas, Sotirios Patsilinakos, George Mertzanos et al. · International Journal of Cardiology · 2006 · 75 citations

Recent-onset Atrial Fibrillation, Conversion Efficacy, Cardiac Anaesthesia +8